Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039445 | SCV000063129 | likely benign | not specified | 2016-11-15 | criteria provided, single submitter | clinical testing | p.Val303Met in exon 7 of DSC2: This variant has been identified in 0.7% (120/165 12) of South Asian chromosomes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs145560678). This vari ant was previously reported in 1 individual with DCM (Garcia-Pavia 2011). Howeve r, given the high frequency of this variant in the general population, it is not expected to have clinical significance. |
Gene |
RCV000039445 | SCV000233423 | benign | not specified | 2017-02-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000227622 | SCV000290740 | benign | Arrhythmogenic right ventricular dysplasia 11 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621747 | SCV000736344 | likely benign | Cardiovascular phenotype | 2018-09-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000227622 | SCV000743496 | likely benign | Arrhythmogenic right ventricular dysplasia 11 | 2017-07-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771128 | SCV000902897 | likely benign | Cardiomyopathy | 2018-03-09 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000039445 | SCV000919275 | likely benign | not specified | 2020-11-02 | criteria provided, single submitter | clinical testing | Variant summary: DSC2 c.907G>A (p.Val303Met) results in a conservative amino acid change located in the Cadherin-like domain of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0011 in 252686 control chromosomes, predominantly at a frequency of 0.0068 within the South Asian subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 680-fold the estimated maximal expected allele frequency for a pathogenic variant in DSC2 causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.907G>A has been reported in the literature in at least one individual affected with cardiomyopathy (e.g. Garcia-Pavia_2011), but also in healthy controls (e.g. Kapplinger_2011). These reports do not provide unequivocal conclusions about association of the variant with Arrhythmia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Nine other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. They have cited the variant as benign/likely benign (n=8) and uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as likely benign. |
Ce |
RCV000858410 | SCV001151502 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | DSC2: BP4 |
Illumina Laboratory Services, |
RCV000227622 | SCV001281728 | uncertain significance | Arrhythmogenic right ventricular dysplasia 11 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
CHEO Genetics Diagnostic Laboratory, |
RCV000771128 | SCV001334028 | benign | Cardiomyopathy | 2018-03-20 | criteria provided, single submitter | clinical testing | |
Al Jalila Children’s Genomics Center, |
RCV000227622 | SCV001984560 | benign | Arrhythmogenic right ventricular dysplasia 11 | 2020-01-08 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000039445 | SCV001921757 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000858410 | SCV001954595 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000858410 | SCV001964350 | likely benign | not provided | no assertion criteria provided | clinical testing |